Heather O'Brian
ArticleFielmann sees profits squeezed in H1
The Fielmann Group reported its Ebitda narrowed to €171.4 million in the first half of 2022 from €186.6 million the year earlier while its net profit slipped to €28.2 million from €37.4 million, as the group increased employees’ salaries amid a shortage of skilled workers while sales continued to be ...
ArticleSynsam keeps up growth as Swedish factory comes online
Sales at the Synsam Group in the second quarter of 2022 increased by a reported 15.3 percent to 1,399 million Swedish crowns (€132.4m), a result the company highlighted was achieved in a competitive market for recruiting opticians, particularly in its home market of Sweden but also in Norway and Denmark. ...
ArticleFielmann invests €65 m in high-tech facility in Czech Republic
The Fielmann Group announced a €65 million investment for a new high-tech eyewear manufacturing and logistics facility in Chomutov in the Czech Republic to support its European growth efforts. The company said that it would produce customised, refined prescription lenses at the new site and mount them into frames sourced ...
ArticleNational Vision cuts sales outlooks as Q2 sales continue decline
National Vision said it was cutting its forecasts for top line growth for the full year, after sales slipped in the second quarter of 2022. Revenues in the three months ended July 2, 2022, decreased by 7.3 percent compared to the year earlier to $509.6 million and were positively impacted ...
ArticleWarby Parker slashes sales outlook, cuts jobs despite 14% growth in Q2
Warby Parker slashed its sales outlook for the full year and unveiled corporate job cuts and other cost-cutting measures despite solid growth in the second quarter, as it highlighted the “uncertain macroeconomic environment” and signs of industry-wide weakness in demand for eyewear.
ArticleFielmann’s Q2 sales rise 8%, profits squeezed
The Fielmann Group reported external sales of €505 million in the second quarter of 2022, an eight percent increase compared to the year earlier, despite a drag on its top line performance from the prolonged Covid-19 pandemic and as consumer confidence increasingly takes a hit from high inflation and rising ...
ArticleItalia Independent plans cash call, restructuring after losses widen in 2021
The Italia Independent Group announced plans to seek fresh capital from shareholders and carry out a restructuring after losses in 2021 jumped to €24.0 million from €2.8 million the year earlier. Losses for the year came after €18.1 million in writedowns and provisions compared to €2.0 million in 2020.
ArticleBausch + Lomb sees earnings squeezed in Q1, confirms FY sales guidance
Bausch + Lomb reported an adjusted Ebitda of $170 million in the first quarter of 2022, down from $198 million the year earlier, as growth in organic revenues was more than offset by foreign currency headwinds and the negative impact from new Covid-19 lockdowns in China. For the full year, ...
ArticleWarby Parker confirms FY outlook after Q1 sales take Omicron hit
Warby Parker confirmed its outlook for financial year 2022 after the onset of the Omicron variant negatively impacted revenues for the first quarter ended March 31. Quarterly sales increased by 10.3 percent to $153.2 million but would have been an estimated $15.0 million higher without the negative impact of the ...
ArticleBausch + Lomb sees 5% organic sales growth in Q1 as IPO wraps up
Bausch Health sold 35 million common Bausch + Lomb shares, or a 10.0 percent stake, at a price of $18.00 per share, in an initial public offering yielding gross proceeds of $630 million and valuing its subsidiary at about $6,300 million.
ArticleMarcolin builds on 2021 momentum in Q1
After bouncing back from the Covid-19 pandemic in 2021, the Marcolin Group built on its recovery in the first quarter of 2022, with sales posting a 19.5 percent year-on-year gain to reach €129.8 million and rising 15.3 percent at constant currency rates. Sales in financial year 2021, for which results ...
